Page last updated: 2024-08-24

prulifloxacin and Pseudomonas Infections

prulifloxacin has been researched along with Pseudomonas Infections in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kazuno, K; Kise, M; Kitano, M; Matsuda, M; Matsuoka, M; Ozaki, M; Segawa, J; Shirahase, I; Tomii, Y1
Marchese, A; Roveta, S; Schito, AM; Schito, GC1
Ida, T; Kariyama, R; Kato, Y; Kumon, H; Maebashi, K; Mikuniya, T; Monden, K1

Other Studies

3 other study(ies) available for prulifloxacin and Pseudomonas Infections

ArticleYear
Studies on pyridonecarboxylic acids. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3- carboxylic acids.
    Journal of medicinal chemistry, 1992, Dec-11, Volume: 35, Issue:25

    Topics: Administration, Oral; Animals; Anti-Infective Agents; Carboxylic Acids; Escherichia coli Infections; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Pseudomonas Infections; Quinolones; Structure-Activity Relationship

1992
Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa.
    International journal of antimicrobial agents, 2005, Volume: 26, Issue:5

    Topics: Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Cystic Fibrosis; Dioxolanes; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Opportunistic Infections; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Quinolones

2005
Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2007, Volume: 13, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Catheters, Indwelling; Dioxolanes; Disease Models, Animal; Drug Therapy, Combination; Female; Fluoroquinolones; Fosfomycin; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Piperazines; Polyethylene; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Rats; Urinary Catheterization; Urinary Tract Infections

2007